Welcome to Barramundi
Barramundi is an investment company listed on the New Zealand Stock Exchange. We invest in small, growing Australian companies and seek to create shareholder value through growing our investment assets and paying dividends to shareholders.
The investment portfolio of Barramundi is managed by Fisher Funds Management Limited (“Fisher Funds” or the “Manager”), an investment manager with a track record of successfully investing in small company shares.
The Barramundi portfolio
Pharmaxis published results from its Phase 3 Bronchitol drug trial for people suffering from Cystic Fibrosis. The results support the early and sustained improvement in lung function in Cystic Fibrosis patients seen in the first phase III study (CF301). Read more.
Getting Information
Latest News
Click on the articles below to read more:
2010 Calendar
18 Jun 2010
Dividend payment
|
30 Jun 2010
Financial year end |
24 Aug 2010
Warrant exercise date |
Sep 2010
Mailout of annual report |
Sep 2010
Dividend payment |
|
Oct 2010
Annual shareholders meeting |
|
|
Latest NAV $0.8326 (as at 28 July 2010)
Click here for more market announcements
Current Share Price Information
| Description | Code | Last | | Barramundi Shares | BRM | $0.69 | | Barramundi Warrants | BRMWB | $0.040 |
* this table is live and is updated as trading occurs
Weekly Price Chart - Barramundi Shares(BRM)
Weekly Price Chart - Barramundi Warrants (BRMWB)
Click
here to view the Barramundi NAV v Share Price. |